Inhibition of leptin receptors through plant-derived ligands for liver fibrosis drug development

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; 115:209-18.10.1172/JCI2428254643515690074Search in Google Scholar

2. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen- producing cells of normal rat liver. Proc Natl Acad Sci USA. 1985; 82: 8681-5.10.1073/pnas.82.24.86813915003909149Open DOISearch in Google Scholar

3. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001; 21:311-35.10.1055/s-2001-1755011586463Open DOISearch in Google Scholar

4. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275:2247-50.10.1074/jbc.275.4.224710644669Search in Google Scholar

5. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 2003; 299:890-3.10.1126/science.107956212574630Search in Google Scholar

6. Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, et al. Proangiogenic role of tumoractivated hepatic stellate cells in experimental melanoma metastasis. Hepatology. 2003; 37:674-85.10.1053/jhep.2003.5006812601365Open DOISearch in Google Scholar

7. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Ann Rev Pharm Toxicol. 2005; 45:605-28.10.1146/annurev.pharmtox.45.120403.09590615471534Open DOISearch in Google Scholar

8. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004; 10:429-34.10.1038/nm100615152612Open DOISearch in Google Scholar

9. Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004; 36:231-42.10.1016/j.dld.2004.01.00315115333Open DOISearch in Google Scholar

10. Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology. 1999; 29: 1818-24.10.1002/hep.51029060110347125Open DOISearch in Google Scholar

11. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122:1399-410.10.1053/gast.2002.3299511984526Search in Google Scholar

12. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002; 35:762-71.10.1053/jhep.2002.32029293519311915021Open DOISearch in Google Scholar

13. Hopkins AL, Groom CR. The druggable genome. Nature Rev Drug Discov. 2002; 1:727-30.10.1038/nrd89212209152Search in Google Scholar

14. Shin MS, Kang EH, Lee YI. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antiviral Res. 2005; 67: 163-8.10.1016/j.antiviral.2005.06.00516118024Search in Google Scholar

15. Papadopoulos V, Kapsis A, Li H, Amri H, Hardwick M, Culty M, et al. Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. Anticancer Res. 2000; 20:2835-47.Search in Google Scholar

16. Dewint P, Gossye V, De Bosscher K, Vanden Berghe W, Van Beneden K, Deforce D, et al. A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J Immunol 2008; 180: 2608-15.10.4049/jimmunol.180.4.260818250472Search in Google Scholar

17. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2011; 39:D38-51.10.1093/nar/gkq1172301373321097890Open DOISearch in Google Scholar

18. Poornima C, Asif SM, Amir Asad A, Vibhika G, Jitendra S, Singh R. Homology modeling and active site analysis of leptin receptor of homo sapiens involved in obesity. Int J Appl Biol Pharm Technol. 2010; 1:747-53.Search in Google Scholar

19. Schwede T, Kopp J, Guex N, Peitsch MC. SWISSMODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003; 31:3381-5.10.1093/nar/gkg52016892712824332Open DOISearch in Google Scholar

20. Guex N, Peitsch MC. SWISS-MODEL and the Swiss- PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997; 18:2714-23.10.1002/elps.11501815059504803Open DOISearch in Google Scholar

21. Peitsch MC. Protein modeling by E-mail. Biol Technol. 1995; 13:658-60.10.1038/nbt0795-658Open DOISearch in Google Scholar

20. Bhattacharya A, Tejero R, Montelione GT. Evaluating protein structures determined by structural genomics consortia. Proteins. 2007; 66:778-95.10.1002/prot.2116517186527Search in Google Scholar

21. DeLano WL. The PyMOL molecular graphics system. 2002 (http://www.ccp4.ac.uk/newsletters/newsletter40.pdf#page=44).Search in Google Scholar

22. Laurie AT, Jackson RM. Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites. Bioinformatics. 2005; 21:1908-16.10.1093/bioinformatics/bti315Open DOISearch in Google Scholar

23. Kaiser J. Chemists want NIH to curtail database. Science. 2005; 308:774.10.1126/science.308.5723.774aSearch in Google Scholar

24. Bolton EE, Kim S, Bryant SH. PubChem3D: Diversity of shape. J Cheminform. 2011; 21:3-9.10.1186/1758-2946-3-9Search in Google Scholar

25. Macindoe G, Mavridis L, Venkatraman V, Devignes MD, Ritchie DW. HexServer: an FFT-based protein docking server powered by graphics processors. Nucleic Acids Res. 2010; 38:W445-9.10.1093/nar/gkq311Open DOISearch in Google Scholar

26. Fallowfield JA, Kendall TJ, Iredale JP. Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis. 2006; 10:481-97.10.1016/j.cld.2006.08.022Open DOISearch in Google Scholar

27. Sherman IA, Pappas SC, Fisher MM. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am J Physiol. 1990; 258:H460-5.10.1152/ajpheart.1990.258.2.H460Search in Google Scholar

28. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371:838-51.10.1016/S0140-6736(08)60383-9Search in Google Scholar

29. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol. 2004; 1:98-105.10.1038/ncpgasthep0055Search in Google Scholar

30. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; 115:209-18.10.1172/JCI24282Search in Google Scholar

31. Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol. 2005; 3:95-107.10.1016/S1542-3565(04)00445-8Open DOISearch in Google Scholar

32. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001; 21:437-51.10.1055/s-2001-17558Open DOISearch in Google Scholar

33. Wu J, Danielsson A. Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates. Scand J Gastroenterol. 1994; 29:385-91.10.3109/00365529409096827Open DOISearch in Google Scholar

34. Guner OF. The impact of pharmacophore modeling in drug design. IDrugs. 2005; 8:567-72.15973565Search in Google Scholar

35. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-32.10.1038/372425a0Search in Google Scholar

36. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, OB-R.Cell. 1995; 83:1263-71.10.1016/0092-8674(95)90151-5Open DOISearch in Google Scholar

37. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev. 1996; 7:303-9.10.1016/S1359-6101(96)00040-8Open DOISearch in Google Scholar

38. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, et al. Crystal structure of the obese protein leptin-E100. Nature. 1997; 387:206-9.10.1038/387206a0Search in Google Scholar

39. Kline AD, Becker GW, Churgay LM, Landen BE, Martin DK, Muth WL, et al. Leptin is a four-helix bundle: secondary structure by NMR. FEBS Lett. 1997; 407:239-42.10.1016/S0014-5793(97)00353-0Search in Google Scholar

40. Hiroike T, Higo J, Jingami H, Toh H. Homology modeling of human leptin/leptin receptor complex. Biochem Biophys Res Commun. 2000; 275:154-8.10.1006/bbrc.2000.3275Search in Google Scholar

41. Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol. 1998; 280:1-9.10.1006/jmbi.1998.1843Search in Google Scholar

42. Mallat A, Lotersztajn S. Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol. 1996; 25:405-13.10.1016/S0168-8278(96)80130-9Open DOISearch in Google Scholar

43. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem. 2000; 275:715-22.10.1074/jbc.M006577200Search in Google Scholar

44. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, et al. Ligands of peroxisome proliferatoractivated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterol. 2000; 119:466-78.10.1053/gast.2000.9365Search in Google Scholar

45. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, et al. Peroxisome proliferatoractivated receptor gamma transcriptional regulation is involved in plateletderived growth factor-induced proliferation of human hepatic stellate cells. Hepatol. 2000; 31:101-8.10.1002/hep.510310117Open DOISearch in Google Scholar

46. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati- Baroni G, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterol. 2002; 122: 1924-40.10.1053/gast.2002.33666Search in Google Scholar

47. Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatol. 1999; 29: 1818-24.10.1002/hep.510290601Open DOISearch in Google Scholar

48. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterol. 2002; 122: 1399-410.10.1053/gast.2002.32995Search in Google Scholar

49. Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998; 104:170-8.10.1016/S0002-9343(97)00397-5Search in Google Scholar

50. De Smet PA. Herbal remedies. N Engl J Med. 2002; 347:2046-56.10.1056/NEJMra02039812490687Search in Google Scholar

51. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001; 135:262-8.10.7326/0003-4819-135-4-200108210-0001111511141Search in Google Scholar

52. Strader DB, Bacon BR, Lindsay KL, La Breque DR, Morgan T, Wright EC, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol. 2002; 97:2391-7.10.1111/j.1572-0241.2002.05993.x12358262Search in Google Scholar

53. Flora KD, Rosen HR, Brenner KG. The use of neuropathic remedies for chronic liver disease. Am J Gastroenterol. 1996; 91:2654-5. Search in Google Scholar